Mark W Clemens Selected Research

Breast Implants (Breast Implant)

10/2022	2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL.
9/2022	Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines.
1/2022	Breast Implant-associated Anaplastic Large Cell Lymphoma: A Prospective Series of 52 Patients.
1/2022	Breast Implant-associated Anaplastic Large Cell Lymphoma Diagnosis 6 Years After Implant Removal: A Case Report.
12/2021	Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease.
12/2021	Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.
11/2021	Granzyme B Is a Biomarker for Suspicion of Malignant Seromas Around Breast Implants.
10/2021	The surface topography of silicone breast implants mediates the foreign body response in mice, rabbits and humans.
10/2021	Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: Report of the scientific committee on health, emerging and environmental risks (SCHEER).
5/2021	Management of Symptomatic Patients with Textured Implants.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark W Clemens Research Topics

Disease

58	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2022 - 08/2014
25	Neoplasms (Cancer) 12/2021 - 05/2008
15	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 01/2016
11	Seroma 01/2022 - 05/2013
10	Lymphoma (Lymphomas) 12/2021 - 07/2015
9	Infections 01/2022 - 02/2011
5	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2016
4	Wounds and Injuries (Trauma) 01/2021 - 09/2007
3	Disease Progression 01/2022 - 01/2018
3	Contracture 05/2021 - 11/2018
3	Inflammation (Inflammations) 01/2021 - 01/2018
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 11/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 01/2019
2	Cicatrix (Scar) 12/2020 - 05/2010
2	Lymphadenopathy 11/2020 - 10/2015
2	Rupture 01/2020 - 01/2019
2	Fat Necrosis 01/2020 - 02/2014
2	Obesity 01/2020 - 07/2015
2	Necrosis 01/2020 - 01/2019
2	Skin Neoplasms (Skin Cancer) 01/2015 - 02/2014
2	Keloid 05/2010 - 01/2009
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2022
1	Enteropathy-Associated T-Cell Lymphoma 01/2022
1	Pneumonia (Pneumonitis) 12/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021
1	Foreign Bodies (Foreign Body) 10/2021
1	Fibrosis (Cirrhosis) 10/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Primary Effusion Lymphoma 04/2020
1	Burns 01/2020
1	Stillbirth 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2019
1	Rheumatoid Arthritis 01/2019
1	Mastodynia 11/2018
1	Extranodal NK-T-Cell Lymphoma 02/2018
1	Hypersensitivity (Allergy) 01/2018
1	Spontaneous Remission 01/2018
1	Cellulitis 10/2017
1	Triple Negative Breast Neoplasms 03/2017
1	Nausea 04/2016
1	Pain (Aches) 04/2016
1	Ventral Hernia 11/2014

Drug/Important Bio-Agent (IBA)

12	Capsules (Microcapsules)IBA 12/2021 - 09/2009
3	PlasticsIBA 01/2022 - 01/2017
3	CytokinesIBA 11/2021 - 01/2018
3	SiliconesIBA 10/2021 - 01/2019
3	Phenobarbital (Luminal)FDA Link 01/2020 - 03/2017
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2021
2	Opioid Analgesics (Opioids)IBA 12/2020 - 04/2016
2	Interleukin-13IBA 01/2020 - 01/2018
2	Agent OrangeIBA 01/2015 - 02/2014
1	Granzymes (Granzyme)IBA 11/2021
1	Peptide Hydrolases (Proteases)FDA Link 11/2021
1	LipopolysaccharidesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Particulate MatterIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	EndotoxinsIBA 01/2021
1	Activin Receptors (Activin Receptor)IBA 05/2020
1	InterferonsIBA 01/2020
1	EnzymesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	HLA-A Antigens (HLA-A)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2018
1	AntigensIBA 01/2018
1	AntiemeticsIBA 04/2016
1	Fentanyl (Sublimaze)FDA LinkGeneric 04/2016
1	diclofenac hydroxyethylpyrrolidine (DIEP)FDA Link 02/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2010
1	Oxygen (Dioxygen)IBA 10/2010
1	collagen-glycosaminoglycan copolymerIBA 05/2010

Therapy/Procedure

62	Breast Implants (Breast Implant) 10/2022 - 08/2014
13	Mammaplasty (Breast Reconstruction) 01/2022 - 05/2008
7	Therapeutics 12/2021 - 01/2009
5	Radiotherapy 01/2022 - 11/2012
5	Mastectomy (Mammectomy) 01/2021 - 03/2017
4	Tissue Expansion Devices (Tissue Expander) 01/2021 - 06/2016
3	Segmental Mastectomy (Lumpectomy) 01/2021 - 10/2016
2	Free Tissue Flaps 01/2022 - 01/2009
2	Debridement 10/2010 - 01/2008
1	Device Removal (Removal, Device) 01/2022
1	Patient Readmission 12/2021
1	Operative Time 12/2020
1	Length of Stay 12/2020
1	Drug Therapy (Chemotherapy) 11/2020
1	Prostheses and Implants (Prosthesis) 01/2020
1	Organ Transplantation 01/2020
1	Operative Surgical Procedures 10/2016
1	Duration of Therapy 06/2016
1	Abdominoplasty 11/2014
1	Myocutaneous Flap 02/2011
1	Negative-Pressure Wound Therapy 10/2010